期刊
ONCOGENE
卷 25, 期 51, 页码 6817-6830出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.onc.1209942
关键词
NF-kappa B; IKK; cancer; cancer therapy; inhibitors; signal transduction
Abundant data support a key role for the transcription factor nuclear factor-kappa B (NF-kappa B) signa ling pathway in controlling the initiation and progression of human cancer. NF-kappa B and associated regulatory proteins such as I kappa B kinase (IKK) are activated downstream of many onco-proteins and there is much evidence for the activation of NF-kappa B-dependent target genes in a variety of solid tumors and hematologic malignancies. This review focuses on the mechanisms by which the NF-kappa B pathway is activated in cancer and on the oncogenic functions controlled by activated NF-kappa B. Additionally, the effects of NF-kappa B activation in tumors relative to cancer therapy are also discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据